Critical Quality Attribute Investigation and Analytical Method Establishment for Glyco-Site-Specific Anti-HER2 Bispecific ADC

Xiaojuan Yu, Lele Wang, Weirong Cao, Yao Tang, Tao Tang, Yangwei Fu, Yalan Yang, Chuanfei Yu, Yan Li, Lan Wang

Open source

DOI
10.3390/ph19091495
Published
09
Container
Pharmaceuticals
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19091495,
  title = {Critical Quality Attribute Investigation and Analytical Method Establishment for Glyco-Site-Specific Anti-HER2 Bispecific ADC},
  author = {Xiaojuan Yu and Lele Wang and Weirong Cao and Yao Tang and Tao Tang and Yangwei Fu and Yalan Yang and Chuanfei Yu and Yan Li and Lan Wang},
  year = {2026},
  journal = {Pharmaceuticals},
  doi = {10.3390/ph19091495},
  url = {https://doi.org/10.3390/ph19091495}
}

RIS

TY  - JOUR
TI  - Critical Quality Attribute Investigation and Analytical Method Establishment for Glyco-Site-Specific Anti-HER2 Bispecific ADC
AU  - Xiaojuan Yu
AU  - Lele Wang
AU  - Weirong Cao
AU  - Yao Tang
AU  - Tao Tang
AU  - Yangwei Fu
AU  - Yalan Yang
AU  - Chuanfei Yu
AU  - Yan Li
AU  - Lan Wang
PY  - 2026
JO  - Pharmaceuticals
DO  - 10.3390/ph19091495
UR  - https://doi.org/10.3390/ph19091495
ER  - 

APA

Yu, X., Wang, L., Cao, W., Tang, Y., Tang, T., Fu, Y., Yang, Y., Yu, C., Li, Y., & Wang, L. (2026). Critical Quality Attribute Investigation and Analytical Method Establishment for Glyco-Site-Specific Anti-HER2 Bispecific ADC. Pharmaceuticals. https://doi.org/10.3390/ph19091495

Source records